Clinical and biomarker changes in dominantly inherited Alzheimer's disease

Cited by (309)

Items 201–300 of 309

1. Artificial intelligence and neuropsychological measures: the case of Alzheimer's disease
   Battista, Petronilla, Salvatore, Christian, Berlingeri, Manuela, Cerasa, Antonio, Castiglioni, Isabella · 2020 · Neuroscience & Biobehavioral Reviews
2. Integrating longitudinal information in hippocampal volume measurements for the early detection of Alzheimer's disease
   Chincarini, Andrea, Sensi, Francesco, Rei, Luca, Gemme, Gianluca, Squarcia, Sandro, Longo, Renata, Brun, Francesco, Tangaro, Sabina, Bellotti, Roberto, Amoroso, Nicola et al. · 2016 · NeuroImage
3. Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease
   Schindler, Suzanne E., Li, Yan, Todd, Kaitlin W., Herries, Elizabeth M., Henson, Rachel L., Gray, Julia D., Wang, Guoqiao, Graham, Danielle L., Shaw, Leslie M., Trojanowski, John Q. et al. · 2019 · Alzheimer's & Dementia
4. Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment
   Fernández-Blázquez, Miguel A., Ávila-Villanueva, Marina, Maestú, Fernando, Medina, Miguel · 2016 · Journal of Alzheimer's Disease
5. Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients
   Di Domenico, Fabio, Pupo, Gilda, Giraldo, Esther, Badìa, Mari-Carmen, Monllor, Paloma, Lloret, Ana, Eugenia Schininà, Maria, Giorgi, Alessandra, Cini, Chiara, Tramutola, Antonella et al. · 2016 · Free Radical Biology and Medicine
6. Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
   Mroczko, Barbara, Groblewska, Magdalena, Litman-Zawadzka, Ala, Kornhuber, Johannes, Lewczuk, Piotr · 2018 · International Journal of Molecular Sciences
7. Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease
   Irwin, David J., Trojanowski, John Q., Grossman, Murray · 2013 · Frontiers in Aging Neuroscience
8. Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes
   Gómez-Isla, Teresa, Frosch, Matthew P. · 2022 · Nature Reviews Neurology
9. Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies
   Dominantly Inherited Alzheimer Network, Ringman, John M., Goate, Alison, Masters, Colin L., Cairns, Nigel J., Danek, Adrian, Graff-Radford, Neill, Ghetti, Bernardino, Morris, John C. · 2014 · Current Neurology and Neuroscience Reports
10. Amyloid plaque structure and cell surface interactions of β-amyloid fibrils revealed by electron tomography
    Han, Shen, Kollmer, Marius, Markx, Daniel, Claus, Stephanie, Walther, Paul, Fändrich, Marcus · 2017 · Scientific Reports
11. Axonal energy metabolism, and the effects in aging and neurodegenerative diseases
    Yang, Sen, Park, Jung Hyun, Lu, Hui-Chen · 2023 · Molecular Neurodegeneration
12. Proteopathic tau primes and activates interleukin-1β via myeloid-cell-specific MyD88- and NLRP3-ASC-inflammasome pathway
    Jiang, Shanya, Maphis, Nicole M., Binder, Jessica, Chisholm, Devon, Weston, Lea, Duran, Walter, Peterson, Crina, Zimmerman, Amber, Mandell, Michael A., Jett, Stephen D. et al. · 2021 · Cell Reports
13. The dynamics of biomarkers across the clinical spectrum of Alzheimer's disease
    Hadjichrysanthou, Christoforos, Evans, Stephanie, Bajaj, Sumali, Siakallis, Loizos C., McRae-McKee, Kevin, de Wolf, Frank, Anderson, Roy M., the Alzheimer’s Disease Neuroimaging Initiative · 2020 · Alzheimer's Research & Therapy
14. Phenotypic heterogeneity in dementia: a challenge for epidemiology and biomarker studies
    Ryan, Joanne, Fransquet, Peter, Wrigglesworth, Jo, Lacaze, Paul · 2018 · Frontiers in Public Health
15. Target engagement in an Alzheimer trial: crenezumab lowers amyloid β oligomers in cerebrospinal fluid
    Yang, Ting, Dang, Yifan, Ostaszewski, Beth, Mengel, David, Steffen, Verena, Rabe, Christina, Bittner, Tobias, Walsh, Dominic M., Selkoe, Dennis J. · 2019 · Annals of Neurology
16. Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, <i>APOE</i> ε4, and Cognitive Impairment
    Therriault, Joseph, Pascoal, Tharick A., Benedet, Andrea L., Tissot, Cecile, Savard, Melissa, Chamoun, Mira, Lussier, Firoza, Kang, Min Su, Berzgin, Gleb, Wang, Tina et al. · 2021 · Neurology
17. Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease
    Butterfield, D. Allan, Boyd-Kimball, Debra · 2020 · Antioxidants
18. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
    Mattsson, Niklas, Groot, Colin, Jansen, Willemijn J., Landau, Susan M., Villemagne, Victor L., Engelborghs, Sebastiaan, Mintun, Mark M., Lleo, Alberto, Molinuevo, José Luis, Jagust, William J. et al. · 2018 · Alzheimer's &amp; Dementia
19. Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer’s disease: Metabolic basis for dementia
    Xu, Jingshu, Begley, Paul, Church, Stephanie J., Patassini, Stefano, McHarg, Selina, Kureishy, Nina, Hollywood, Katherine A., Waldvogel, Henry J., Liu, Hong, Zhang, Shaoping et al. · 2016 · Scientific Reports
20. Role of imaging in the era of precision medicine
    Giardino, Angela, Gupta, Supriya, Olson, Emmi, Sepulveda, Karla, Lenchik, Leon, Ivanidze, Jana, Rakow-Penner, Rebecca, Patel, Midhir J., Subramaniam, Rathan M., Ganeshan, Dhakshinamoorthy · 2017 · Academic Radiology
21. Phosphorylated Tau-Aβ42 Ratio as a Continuous Trait for Biomarker Discovery for Early-Stage Alzheimer’s Disease in Multiplex Immunoassay Panels of Cerebrospinal Fluid
    Harari, Oscar, Cruchaga, Carlos, Kauwe, John S.K., Ainscough, Benjamin J., Bales, Kelly, Pickering, Eve H., Bertelsen, Sarah, Fagan, Anne M., Holtzman, David M., Morris, John C. et al. · 2014 · Biological Psychiatry
22. Neuropathologic assessment of participants in two multi‐center longitudinal observational studies: The <scp>A</scp>lzheimer <scp>D</scp>isease <scp>N</scp>euroimaging <scp>I</scp>nitiative (<scp>ADNI</scp>) and the <scp>D</scp>ominantly <scp>I</scp>nherited <scp>A</scp>lzheimer <scp>N</scp>etwork (<scp>DIAN</scp>)
    Cairns, Nigel J., Perrin, Richard J., Franklin, Erin E., Carter, Deborah, Vincent, Benjamin, Xie, Mingqiang, Bateman, Randall J., Benzinger, Tammie, Friedrichsen, Karl, Brooks, William S. et al. · 2015 · Neuropathology
23. Effects of physical exercise on Alzheimer's disease biomarkers: a systematic review of intervention studies
    Frederiksen, Kristian Steen, Gjerum, Le, Waldemar, Gunhild, Hasselbalch, Steen Gregers · 2017 · Journal of Alzheimer s Disease
24. Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer’s disease
    Sung, Yun Ju, Yang, Chengran, Norton, Joanne, Johnson, Matt, Fagan, Anne, Bateman, Randall J., Perrin, Richard J., Morris, John C., Farlow, Martin R., Chhatwal, Jasmeer P. et al. · 2023 · Science Translational Medicine
25. Physiological Roles of β-amyloid in Regulating Synaptic Function: Implications for AD Pathophysiology
    Cai, Wenwen, Li, Linxi, Sang, Shaoming, Pan, Xiaoli, Zhong, Chunjiu · 2023 · Neuroscience Bulletin
26. Imaging of cerebrovascular pathology in animal models of Alzheimer's disease
    Klohs, Jan, Rudin, Markus, Shimshek, Derya R., Beckmann, Nicolau · 2014 · Frontiers in Aging Neuroscience
27. State‐of‐the‐art of lumbar puncture and its place in the journey of patients with Alzheimer's disease
    Hampel, Harald, Shaw, Leslie M., Aisen, Paul, Chen, Christopher, Lleó, Alberto, Iwatsubo, Takeshi, Iwata, Atsushi, Yamada, Masahito, Ikeuchi, Takeshi, Jia, Jianping et al. · 2022 · Alzheimer's &amp; Dementia
28. Fully Automatic Speech-Based Analysis of the Semantic Verbal Fluency Task
    König, Alexandra, Linz, Nicklas, Tröger, Johannes, Wolters, Maria, Alexandersson, Jan, Robert, Phillipe · 2018 · Dementia and Geriatric Cognitive Disorders
29. Preclinical validation of a potent γ-secretase modulator for Alzheimer’s disease prevention
    Rynearson, Kevin D., Ponnusamy, Moorthi, Prikhodko, Olga, Xie, Yuhuan, Zhang, Can, Nguyen, Phuong, Hug, Brenda, Sawa, Mariko, Becker, Ann, Spencer, Brian et al. · 2021 · Journal of Experimental Medicine
30. Tau oligomers in cerebrospinal fluid in Alzheimer's disease
    Sengupta, Urmi, Portelius, Erik, Hansson, Oskar, Farmer, Kathleen, Castillo‐Carranza, Diana, Woltjer, Randall, Zetterberg, Henrik, Galasko, Douglas, Blennow, Kaj, Kayed, Rakez · 2017 · Annals of Clinical and Translational Neurology
31. <i>BDNF</i>Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer’s disease
    Lim, Yen Ying, Hassenstab, Jason, Cruchaga, Carlos, Goate, Alison, Fagan, Anne M., Benzinger, Tammie L. S., Maruff, Paul, Snyder, Peter J., Masters, Colin L., Allegri, Ricardo et al. · 2016 · Brain
32. Efficacy and mechanism of cGAMP to suppress Alzheimer’s disease by elevating TREM2
    Xu, Qiming, Xu, Wei, Cheng, Hao, Yuan, Hong, Tan, Xiangshi · 2019 · Brain, Behavior, and Immunity
33. Disrupted functional and structural networks in cognitively normal elderly subjects with the APOE ɛ4 allele
    Chen, Yaojing, Chen, Kewei, Zhang, Junying, Li, Xin, Shu, Ni, Wang, Jun, Zhang, Zhanjun, Reiman, Eric M · 2015 · Neuropsychopharmacology
34. Apolipoprotein E Genotype Affects Size of ApoE Complexes in Cerebrospinal Fluid
    Heinsinger, Nicolette Mary, Gachechiladze, Mariam Alexandra, Rebeck, G. William · 2016 · Journal of Neuropathology &amp; Experimental Neurology
35. Neuropsychological changes in asymptomatic persons with Alzheimer disease neuropathology
    Monsell, Sarah E., Mock, Charles, Hassenstab, Jason, Roe, Catherine M., Cairns, Nigel J., Morris, John C., Kukull, Walter · 2014 · Neurology
36. Structural neuroimaging in preclinical dementia: From microstructural deficits and grey matter atrophy to macroscale connectomic changes
    Mak, Elijah, Gabel, Silvy, Mirette, Habib, Su, Li, Williams, Guy B, Waldman, Adam, Wells, Katie, Ritchie, Karen, Ritchie, Craig, O’Brien, John · 2017 · Ageing Research Reviews
37. Autosomal dominant and sporadic late onset Alzheimer's disease share a common<i>in vivo</i>pathophysiology
    Morris, John C, Weiner, Michael, Xiong, Chengjie, Beckett, Laurel, Coble, Dean, Saito, Naomi, Aisen, Paul S, Allegri, Ricardo, Benzinger, Tammie L S, Berman, Sarah B et al. · 2022 · Brain
38. Emerging β-amyloid pathology and accelerated cortical atrophy
    Mattsson, Niklas, Insel, Philip S., Nosheny, Rachel, Tosun, Duygu, Trojanowski, John Q., Shaw, Leslie M., Jack, Clifford R., Donohue, Michael C., Weiner, Michael W. · 2014 · JAMA Neurology
39. The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease
    Blennow, Kaj, Zetterberg, Henrik · 2013 · Medical Clinics of North America
40. Selective Worsening of Brain Injury Biomarker Abnormalities in Cognitively Normal Elderly Persons With β-Amyloidosis
    Knopman, David S., Jack, Clifford R., Wiste, Heather J., Weigand, Stephen D., Vemuri, Prashanthi, Lowe, Val J., Kantarci, Kejal, Gunter, Jeffrey L., Senjem, Matthew L., Mielke, Michelle M. et al. · 2013 · JAMA Neurology
41. The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease
    for the Dominantly Inherited Alzheimer Network (DIAN), Twohig, Daniel, Rodriguez-Vieitez, Elena, Sando, Sigrid B., Berge, Guro, Lauridsen, Camilla, Møller, Ina, Grøntvedt, Gøril R., Bråthen, Geir, Patra, Kalicharan et al. · 2018 · Acta Neuropathologica Communications
42. Hippocampal Deficits in Amyloid-β-Related Rodent Models of Alzheimer’s Disease
    Vyas, Yukti, Montgomery, Johanna M., Cheyne, Juliette E. · 2020 · Frontiers in Neuroscience
43. Increase of TREM2 during Aging of an Alzheimer’s Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis
    Brendel, Matthias, Kleinberger, Gernot, Probst, Federico, Jaworska, Anna, Overhoff, Felix, Blume, Tanja, Albert, Nathalie L., Carlsen, Janette, Lindner, Simon, Gildehaus, Franz Josef et al. · 2017 · Frontiers in Aging Neuroscience
44. The role of lifestyle factors and sleep duration for late-onset dementia: a cohort study
    Larsson, Susanna C., Wolk, Alicja · 2018 · Journal of Alzheimer's Disease
45. Selective Secretase Targeting for Alzheimer’s Disease Therapy
    Miranda, Alvaro, Montiel, Enrique, Ulrich, Henning, Paz, Cristian · 2021 · Journal of Alzheimer s Disease
46. A comprehensive analysis of methods for assessing polygenic burden on Alzheimer’s disease pathology and risk beyond APOE
    Altmann, Andre, Scelsi, Marzia A, Shoai, Maryam, de Silva, Eric, Aksman, Leon M, Cash, David M, Hardy, John, Schott, Jonathan M, Alzheimer’s Disease Neuroimaging Initiative · 2020 · Brain Communications
47. The experience of vivid autobiographical reminiscence is supported by subjective content representations in the precuneus
    Sreekumar, Vishnu, Nielson, Dylan M., Smith, Troy A., Dennis, Simon J., Sederberg, Per B. · 2018 · Scientific Reports
48. Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study
    Sanchez, Justin S., Hanseeuw, Bernard J., Lopera, Francisco, Sperling, Reisa A., Baena, Ana, Bocanegra, Yamile, Aguillon, David, Guzmán-Vélez, Edmarie, Pardilla-Delgado, Enmanuelle, Ramirez-Gomez, Liliana et al. · 2021 · Alzheimer's Research &amp; Therapy
49. Language impairment in Alzheimer’s disease—Robust and explainable evidence for AD-related deterioration of spontaneous speech through multilingual machine learning
    Lindsay, Hali, Tröger, Johannes, König, Alexandra · 2021 · Frontiers in Aging Neuroscience
50. Turning the tide on Alzheimer’s disease: modulation of γ-secretase
    Luo, Joanna E., Li, Yue-Ming · 2022 · Cell &amp; Bioscience
51. In vivo imaging reveals sigmoidal growth kinetic of β-amyloid plaques
    Burgold, Steffen, Filser, Severin, Dorostkar, Mario M, Schmidt, Boris, Herms, Jochen · 2014 · Acta Neuropathologica Communications
52. Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group
    Su, Yi, Blazey, Tyler M., Owen, Christopher J., Christensen, Jon J., Friedrichsen, Karl, Joseph-Mathurin, Nelly, Wang, Qing, Hornbeck, Russ C., Ances, Beau M., Snyder, Abraham Z. et al. · 2016 · PLOS ONE
53. Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers
    Remnestål, Julia, Öijerstedt, Linn, Ullgren, Abbe, Olofsson, Jennie, Bergström, Sofia, Kultima, Kim, Ingelsson, Martin, Kilander, Lena, Uhlén, Mathias, Månberg, Anna et al. · 2020 · Translational Neurodegeneration
54. DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer’s disease and dementia
    Tse, Kai‐Hei, Cheng, Aifang, Ma, Fulin, Herrup, Karl · 2018 · Alzheimer's &amp; Dementia
55. Association of plasma P-tau181 with memory decline in non-demented adults
    Therriault, Joseph, Benedet, Andrea L, Pascoal, Tharick A, Lussier, Firoza Z, Tissot, Cecile, Karikari, Thomas K, Ashton, Nicholas J, Chamoun, Mira, Bezgin, Gleb, Mathotaarachchi, Sulantha et al. · 2021 · Brain Communications
56. Exercise-Induced Modulation of Neuroinflammation in Models of Alzheimer’s Disease
    Kelly, Áine M. · 2018 · Brain Plasticity
57. Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study
    Xiong, Chengjie, Jasielec, Mateusz S., Weng, Hua, Fagan, Anne M., Benzinger, Tammie L.S., Head, Denise, Hassenstab, Jason, Grant, Elizabeth, Sutphen, Courtney L., Buckles, Virginia et al. · 2016 · Neurology
58. Quantum Dots as A Theranostic Approach in Alzheimer’s Disease: A Systematic Review
    Villalva, Maria D, Agarwal, Vipul, Ulanova, Marina, Sachdev, Perminder S, Braidy, Nady · 2021 · Nanomedicine
59. Cellular dynamics across aged human brains uncover a multicellular cascade leading to Alzheimer’s disease
    Green, Gilad Sahar, Yang, Hyun‐Sik, Fujita, Masashi, Taga, Mariko, Regev, Aviv, Menon, Vilas, Bennett, David A. A, Habib, Naomi, De Jager, Philip L · 2023 · Alzheimer's &amp; Dementia
60. Tau-directed approaches for the treatment of Alzheimer’s disease: focus on leuco-methylthioninium
    Seripa, Davide, Solfrizzi, Vincenzo, Imbimbo, Bruno P., Daniele, Antonio, Santamato, Andrea, Lozupone, Madia, Zuliani, Giovanni, Greco, Antonio, Logroscino, Giancarlo, Panza, Francesco · 2016 · Expert Review of Neurotherapeutics
61. Pre‐diagnostic cognitive and functional impairment in multiple sporadic neurodegenerative diseases
    Swaddiwudhipong, Nol, Whiteside, David J., Hezemans, Frank H., Street, Duncan, Rowe, James B., Rittman, Timothy · 2023 · Alzheimer's &amp; Dementia
62. Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy
    Zagórska, Agnieszka, Jaromin, Anna · 2020 · Molecules
63. β-amyloid: The known unknowns
    Ayton, Scott, Bush, Ashley I. · 2021 · Ageing Research Reviews
64. Clinical, biological, and imaging features of monogenic Alzheimer’s disease
    Pilotto, Andrea, Padovani, Alessandro, Borroni, Barbara · 2013 · BioMed Research International
65. Explainable machine learning aggregates polygenic risk scores and electronic health records for Alzheimer’s disease prediction
    Gao, Xiaoyi Raymond, Chiariglione, Marion, Qin, Ke, Nuytemans, Karen, Scharre, Douglas W., Li, Yi-Ju, Martin, Eden R. · 2023 · Scientific Reports
66. Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease
    Rosen, Rebecca F., Tomidokoro, Yasushi, Farberg, Aaron S., Dooyema, Jeromy, Ciliax, Brian, Preuss, Todd M., Neubert, Thomas A., Ghiso, Jorge A., LeVine, Harry, Walker, Lary C. · 2016 · Neurobiology of Aging
67. Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls
    Mattsson, Niklas, Insel, Philip S., Donohue, Michael, Jagust, William, Sperling, Reisa, Aisen, Paul, Weiner, Michael W. · 2015 · JAMA Neurology
68. The Role of Chronic Stress as a Trigger for the Alzheimer Disease Continuum
    Ávila-Villanueva, Marina, Gómez-Ramírez, Jaime, Maestú, Fernando, Venero, César, Ávila, Jesús, Fernández-Blázquez, Miguel A. · 2020 · Frontiers in Aging Neuroscience
69. Genetic risk factors for Alzheimer disease: emerging roles of microglia in disease pathomechanisms
    Takatori, Sho, Wang, Wenbo, Iguchi, Akihiro, Tomita, Taisuke · 2019 · Advances in Experimental Medicine and Biology
70. Neuroprotective Roles of the Reverse Transsulfuration Pathway in Alzheimer’s Disease
    Paul, Bindu Diana · 2021 · Frontiers in Aging Neuroscience
71. Thinner cortex in patients with subjective cognitive decline is associated with steeper decline of memory
    Verfaillie, Sander C.J., Slot, Rosalinde E., Tijms, Betty M., Bouwman, Femke, Benedictus, Marije R., Overbeek, Jozefien M., Koene, Teddy, Vrenken, Hugo, Scheltens, Philip, Barkhof, Frederik et al. · 2018 · Neurobiology of Aging
72. Diagnostic biomarkers in Alzheimer’s disease
    Andersen, Emerlee, Casteigne, Bryce, Chapman, William Daniel, Creed, Andrew, Foster, Forrest, Lapins, Allison, Shatz, Rhonna, Sawyer, Russell P. · 2021 · Biomarkers in Neuropsychiatry
73. Mitochondria-Targeted Small Peptide, SS31 Ameliorates Diabetes Induced Mitochondrial Dynamics in Male TallyHO/JngJ Mice
    Bhatti, Jasvinder Singh, Thamarai, Kavya, Kandimalla, Ramesh, Manczak, Maria, Yin, Xiangling, Kumar, Subodh, Vijayan, Murali, Reddy, P. Hemachandra · 2021 · Molecular Neurobiology
74. Quantitative proteomic analysis of the hippocampus in the 5XFAD mouse model at early stages of Alzheimer’s disease pathology
    Hong, Ingie, Kang, Taewook, Yoo, YongCheol, Park, Royun, Lee, Junuk, Lee, Sukwon, Kim, Jeongyeon, Song, Boemjong, Kim, Se-Young, Moon, Minho et al. · 2013 · Journal of Alzheimer s Disease
75. COVID-19 as a Risk Factor for Alzheimer’s Disease
    Golzari-Sorkheh, Mahdieh, Weaver, Donald F., Reed, Mark A. · 2023 · Journal of Alzheimer's Disease
76. Another step forward in blood-based diagnostics for Alzheimer’s disease
    Bateman, Randall J., Barthélemy, Nicolas R., Horie, Kanta · 2020 · Nature Medicine
77. Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration
    Staffaroni, Adam M., Cobigo, Yann, Goh, Sheng‐Yang M., Kornak, John, Bajorek, Lynn, Chiang, Kevin, Appleby, Brian, Bove, Jessica, Bordelon, Yvette, Brannelly, Patrick et al. · 2020 · Alzheimer's &amp; Dementia
78. Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition
    Schelle, Juliane, Häsler, Lisa M., Göpfert, Jens C., Joos, Thomas O., Vanderstichele, Hugo, Stoops, Erik, Mandelkow, Eva‐Maria, Neumann, Ulf, Shimshek, Derya R., Staufenbiel, Matthias et al. · 2017 · Alzheimer's &amp; Dementia
79. Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer disease
    Levin, Johannes, Vöglein, Jonathan, Quiroz, Yakeel T., Bateman, Randall J., Ghisays, Valentina, Lopera, Francisco, McDade, Eric, Reiman, Eric, Tariot, Pierre N., Morris, John C. · 2022 · Alzheimer's &amp; Dementia
80. Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer’s disease-related inhibitory circuit dysfunction in adults with Down syndrome
    Belbin, Olivia, Xiao, Mei-Fang, Xu, Desheng, Carmona-Iragui, Maria, Pegueroles, Jordi, Benejam, Bessy, Videla, Laura, Fernández, Susana, Barroeta, Isabel, Nuñez-Llaves, Raúl et al. · 2020 · Molecular Neurodegeneration
81. The fornix provides multiple biomarkers to characterize circuit disruption in a mouse model of Alzheimer’s disease.
    Badea, Alexandra, Kane, Lauren, Anderson, Robert J., Qi, Yi, Foster, Mark, Cofer, Gary P., Medvitz, Neil, Buckley, Anne F., Badea, Andreas K., Wetsel, William C. et al. · 2016 · NeuroImage
82. Charting a path toward combination therapy for Alzheimer’s disease
    Stephenson, Diane, Perry, Dan, Bens, Cynthia, Bain, Lisa J, Berry, Donald, Krams, Michael, Sperling, Reisa, Dilts, David, Luthman, Johan, Hanna, Debra et al. · 2015 · Expert Review of Neurotherapeutics
83. Examination of the Effect of Rare Variants in <i>TREM2</i> , <i>ABI3</i> , and <i>PLCG2</i> in LOAD Through Multiple Phenotypes
    Olive, Claudia, Ibanez, Laura, Farias, Fabiana H. Geraldo, Wang, Fengxian, Budde, John P., Norton, Joanne B., Gentsch, Jen, Morris, John C., Li, Zeran, Dube, Umber et al. · 2020 · Journal of Alzheimer’s Disease
84. Retinal examination for the diagnosis of Alzheimer's disease
    Kayabasi, Umur · 2014 · International Journal of Ophthalmic &amp; Pathology
85. Use of amyloid PET across the spectrum of Alzheimer’s disease: clinical utility and associated ethical issues
    Leuzy, Antoine, Zimmer, Eduardo Rigon, Heurling, Kerstin, Rosa-Neto, Pedro, Gauthier, Serge · 2014 · Amyloid
86. Auditory Memory Decay as Reflected by a New Mismatch Negativity Score Is Associated with Episodic Memory in Older Adults at Risk of Dementia
    Laptinskaya, Daria, Thurm, Franka, Küster, Olivia C., Fissler, Patrick, Schlee, Winfried, Kolassa, Stephan, von Arnim, Christine A. F., Kolassa, Iris-Tatjana · 2018 · Frontiers in Aging Neuroscience
87. Progress Update: Fluid and Imaging Biomarkers in Alzheimer’s Disease
    Sutphen, Courtney L., Fagan, Anne M., Holtzman, David M. · 2014 · Biological Psychiatry
88. Protective effects of a mitochondria-targeted small peptide SS31 against hyperglycemia-induced mitochondrial abnormalities in the liver tissues of diabetic mice, Tallyho/JngJ mice
    Bhatti, Jasvinder Singh, Tamarai, Kavya, Kandimalla, Ramesh, Manczak, Maria, Yin, Xiangling, Ramasubramanian, Bhagavathi, Sawant, Neha, Pradeepkiran, Jangampalli Adi, Vijayan, Murali, Kumar, Subodh et al. · 2021 · Mitochondrion
89. MultiTEP platform-based DNA epitope vaccine targeting N-terminus of tau induces strong immune responses and reduces tau pathology in THY-Tau22 mice
    Davtyan, Hayk, Chen, Wesley W., Zagorski, Karen, Davis, Joy, Petrushina, Irina, Kazarian, Konstantin, Cribbs, David H., Agadjanyan, Michael G., Blurton-Jones, Mathew, Ghochikyan, Anahit · 2017 · Vaccine
90. Deep Learning Based Multimodal Progression Modeling for Alzheimer’s Disease
    Yang, Liuqing, Wang, Xifeng, Guo, Qi, Gladstein, Scott, Wooten, Dustin, Li, Tengfei, Robieson, Weining Z, Sun, Yan, Huang, Xin, for the Alzheimer’s Disease Neuroimaging Initiative · 2021 · Statistics in Biopharmaceutical Research
91. Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia
    Llibre-Guerra, Jorge J., Fernandez, M. Victoria, Joseph-Mathurin, Nelly, Bian, Shijia, Carter, Kathleen, Li, Yan, Aschenbrenner, Andrew J., Pottier, Cyril, Sigurdson, Wendy, McDade, Eric et al. · 2025 · Nature Medicine
92. 3D bioengineered neural tissue generated from patient-derived iPSCs mimics time-dependent phenotypes and transcriptional features of Alzheimer’s disease
    Lomoio, Selene, Pandey, Ravi S., Rouleau, Nicolas, Menicacci, Beatrice, Kim, WonHee, Cantley, William L., Haydon, Philip G., Bennett, David A., Young-Pearse, Tracy L., Carter, Gregory W. et al. · 2023 · Molecular Psychiatry
93. Phosphorylated Tau 181 Serum Levels Predict Alzheimer’s Disease in the Preclinical Stage
    Qin, Wei, Li, Fangyu, Jia, Longfei, Wang, Qi, Li, Ying, Wei, Yiping, Li, Yan, Jin, Hongmei, Jia, Jianping · 2022 · Frontiers in Aging Neuroscience
94. Natural Products from Plants and Algae for Treatment of Alzheimer’s Disease: A Review
    Klose, Jana, Griehl, Carola, Roßner, Steffen, Schilling, Stephan · 2022 · Biomolecules
95. Associations of Pulmonary Function with MRI Brain Volumes: A Coordinated Multi-Study Analysis
    Frenzel, Stefan, Bis, Joshua C., Gudmundsson, Elias F., O’Donnell, Adrienne, Simino, Jeannette, Yaqub, Amber, Bartz, Traci M., Brusselle, Guy G. O., Bülow, Robin, DeCarli, Charles S. et al. · 2022 · Journal of Alzheimer's Disease
96. Tracking the earliest pathologic changes in Alzheimer disease
    Landau, Susan M., Frosch, Matthew P. · 2014 · Neurology
97. Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's disease
    Garbarino, Valentina R., Palavicini, Juan Pablo, Melendez, Justin, Barthelemy, Nicolas R., He, Yingxin, Kautz, Tiffany F., Lopez-Cruzan, Marisa, Mathews, Julia J., Xu, Peng, Zhang, Bin et al. · 2025 · Neurotherapeutics
98. Current insights into apolipoprotein E and the immune response in Alzheimer's disease
    Lin, Peter Bor‐Chian, Holtzman, David M. · 2024 · Immunological Reviews
99. Bivariate correlation coefficients in family‐type clustered studies
    Luo, Jingqin, D'Angelo, Gina, Gao, Feng, Ding, Jimin, Xiong, Chengjie · 2015 · Biometrical Journal
100. Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer’s Disease
     Gomar, Jesus J., Conejero-Goldberg, Concepcion, Davies, Peter, Goldberg, Terry E., for the Alzheimer’s Disease Neuroimaging Initiative · 2016 · Journal of Alzheimer’s Disease